BioSpace News Archive

At the direction of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, the Medical CBRN Defense Consortium has released a Request for Information seeking solutions to combat the novel Coronavirus pandemic with a focus on the following areas: 1) Diagnostics/Monitoring, 2) Surveillance, 3) Information Systems for Point of Care, 4) Therapeutics, 5) Prophylactics and 6) Clinical Trials.

Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof. Oliver Sartor has joined Clarity’s Advisory Board.

Scanwell secures exclusive rights to license China FDA-cleared rapid serology test from INNOVITA; Partners with nationwide telehealth provider Lemonaid Health to distribute smartphone-enabled tests to individuals in the U.S.

Company converts CDC guidance into interactive decision-tool in its free epocrates® mobile app, facilitates connectivity to telehealth partners, and ensures availability of commercial lab tests within ordering workflow

The Sapienza University of Rome is now using the digital teaching platform from the international medical imaging and cybersecurity company Sectra (STO: SECT B) to continue its doctor training remotely.

Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the “Company’ or “Hoth”), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from dermatological indications ranging from atopic dermatitis, psoriasis and acne as well as gene therapy treatment for asthmatics, today announced results from a preclinical study demonstrating the potential effectiveness of WEG232,

Ocean Bio-Chem, Inc. (NASDAQ: OBCI), has announced that its subsidiary manufacturing plant, Kinpak Inc. in Montgomery, Alabama has increased its number of shifts and is actively hiring additional personnel to try and meet overwhelming demand for its disinfectant product Performacide ® . In addition, they have taken steps t

Receptor Life Sciences (“RLS”), a leading biopharmaceutical company developing FDA regulated oral and inhaled cannabinoid medicines, today announced that the United States Patent and Trademark Office has issued the Company a Patent for compositions comprising cannabinoids and the company’s oral absorption enhancing excipients: U.S. Patent No. 10,588,974.

Javara Inc., the industry leading Integrated Research Organization (“IRO”), who partners with healthcare organizations to procure and conduct clinical trials, announces a dedicated offering to support the clinical development efforts for a COVID-19 vaccine and treatment options along with a spectrum of infectious diseases

Mesa Biotech Inc., a privately-held, molecular diagnostic company has developed an affordable, 30 minute sample-to-answer molecular testing platform designed for point-of-care (POC) infectious disease diagnosis.